Bookmark and Share

ALUPENT Drug Information Page

Updated 11/08/2010 12:12:41 AM

ProductSourceDateLinkData
ALUPENTMHRA2009-11-3ALUPENT-MHRA-2009-11-3MHRA issued updates for the following drugs: Bisphosphonates: osteonecrosis of the jaw Vigabatrin for infantile spasms: risk of movement disorders and MRI abnormalities Colchicine: reminder on risk of serious and fatal toxicity in overdose Orciprenaline sulphate (Alupent): withdrawal due to unfavourable benefit-risk profile MHRA Swine Flu ADR Portal now extended to include reporting of suspected reactions to swine influenza vaccines Medical and non-medical prescribing: mixing medicines in clinical practice Statins: updated product information on adverse reactions in patient leaflets Oseltamivir (Tamiflu): update to Patient Information Leafl

Joining this website will allow you to recieve emails about any pharmaceutial you are interested in or you can search for other pharmaceuticals on this website. Joining should only take 2 minutes.



Image of checkdrugs.com Logo
© Cardan Technologies Inc

This site is presented as an educational source only and you use it at your own risk. The information on this site is not a substitute for a visit with your doctor or pharmacist. Always talk to your doctor before changing medications or dosage, or if you experience any serious side effects.